% | $
Quotes you view appear here for quick access.

Myrexis, Inc. Message Board

  • tkahn800 tkahn800 Jul 15, 2010 5:08 PM Flag

    Are we there yet?

    Does any one out there know if we're going to phase 3 on Azixia. I know they just touted the results of their phase 2 study. Now what? Management seems perfectly content keeping their mouth shut instead of letting us know what's going on.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Azixa is being presented as a "salvage" drug. The path to approval for drugs in this category is not orderly. Management is probably negotiating with FDA over what will be required; it is expensive bad form to talk in public while negotiating with FDA. It is even possible that marketing will be permitted [for GBM] before anything designated "phase 3" is done.

      The big money is in treatment of brain metastases of "the big 3" (lung, breast and colon cancers). For those to become label indications it will take LOTS more testing. But a little income stream in the mean time would be welcome [and off-label use might make that stream larger].

    • on the way, but will not go at it alone. looking for the right partner now. expect more phase 2 data and a partnership with time. i also expect a partnership on one of the other two drugs, one of those could even be first. that will slow burn.

0.0650.0000(0.00%)May 5 1:25 PMEDT